Patents by Inventor NABRIVA THERAPEUTICS AG

NABRIVA THERAPEUTICS AG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PLEUROMUTILINS AND PROCESS FOR THE PREPARATION OF PLEUROMUTILINS
    Publication number: 20130053571
    Abstract: A process for the preparation of 14-O—[(N-(3-methyl-2-amino-butyryl-piperidinyl)sulfanyl)acetyl]mutilins of formula feasible for large-scale production of high purity products, and wherein the carbon atom at the piperidine ring attached to the sulphur atom is either in the (S)-configuration or in the (R)-configuration, and a new crystalline form of 14-O—[(N-3-methyl-2-(R)-amino-butyryl-piperidine-3(S)-yl)sulfanyl)acetyl]mutilin-hydrochloride.
    Type: Application
    Filed: October 26, 2012
    Publication date: February 28, 2013
    Applicant: NABRIVA THERAPEUTICS AG
    Inventor: NABRIVA THERAPEUTICS AG